Form D · Other
Parsley Health, Inc.
New York, NY · CIK 0001676665
Offering snapshot reported Apr 17, 2018 · SEC filing
- Reported sold
- $12.8M Offering amount: $12.8M
- Investors reported
- 39 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 30, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 17, 2018 | Initial | $12,807,094 | No comparison | 39 | SEC filing |
| Nov 16, 2017 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Jun 2, 2017 | Amendment | $630,000 | $225,000vs Jun 9, 2016 | 17 | SEC filing |
| Jun 2, 2017 | Amendment | $950,000 | $650,000vs Dec 12, 2016 | 14 | SEC filing |
| Dec 12, 2016 | Initial | $300,000 | No comparison | 5 | SEC filing |
| Jun 9, 2016 | Initial | $405,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-310386
Includes conversion of certain indebtedness.
Series A Preferred Stock
Source: Form D, filed Apr 17, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robin Berzin | Director, Executive |
| Catherine Ulrich | Director |
Issuer details
Industry: Other (See others in industry)
Address:
33 Irving Place, 8 Th Fl.
New York, NY, 10003
New York, NY, 10003